About Sooma

Sooma Medical  – Reinventing health and care

Sooma Medical has been breaking new ground in healthcare since 2013. For more than a decade, we have been working closely with foremost experts in psychiatry and neurophysiology to develop safe and medication-free treatment options for depressive disorders and chronic pain – and make them available to patients around the world. Because everyone deserves the best possible care.

The values that shape us

High-quality care with low-threshold access

Relieving symptoms – without generating new ones

Safe and effective treatment without fear of dependency

Better quality of life for everyone, every day, everywhere

A short history of Sooma

Sooma Medical (Sooma Oy) is a Finnish medical device manufacturer established in 2013. Headquartered in Helsinki, Finland, we work at the core of medical research and technology to deliver effective treatment solutions to psychiatric and neurophysiological conditions that affect and inhibit millions of people all over the world.

Grounded in science, our solutions are developed in close cooperation with leading experts in psychiatry and clinical neurophysiology – as they have been from day one. All Sooma medical devices are manufactured in Finland in accordance with the ISO 13485 standard for Quality Management Systems for Medical Devices, ensuring the highest possible quality for clinicians and patients alike. The Sooma tDCS™ treatment solution is also the first and only MDR-approved tDCS treatment system to date.

Sooma tDCS was first launched in 2014 with the first generation of our brain stimulation treatment for major depressive disorder. In 2017, our portfolio expanded further to pain management as Sooma tDCS was approved for the treatment for the long-term pain conditions fibromyalgia and chronic neuropathic pain.

Today, we collaborate with more than 150 clinics, universities, and hospitals worldwide to provide them with state-of-the-art neuromodulation devices for both research purposes and patient care. We are proud to be able to say that, as of 2024, Sooma treatments have helped tens of thousands of patients find relief all over the world.